Prior GP cooperative contact | ||
No (n=136) | Yes (n=127) | |
N (%) | N (%) | |
Age (years), median (IQR) | 68 (60–78) | 70 (58–78) |
Female | 60 (44.1) | 54 (42.5) |
Source of infection | ||
Respiratory tract | 71 (52.2) | 54 (42.5) |
Urinary tract | 16 (11.8) | 24 (18.9) |
Abdominal | 20 (14.7) | 26 (20.5) |
Skin/soft-tissue | 9 (6.6) | 10 (7.9) |
Other | 20 (14.7) | 13 (10.3) |
Comorbidities | ||
Cardiovascular disease | 32 (23.5) | 41 (32.3) |
Diabetes | 39 (28.7) | 42 (33.1) |
Chronic Obstructive Pulmonary Disease | 40 (29.4) | 32 (25.2) |
Kidney disease | 11 (8.1) | 17 (13.4) |
Malignancy | 14 (10.3) | 10 (7.9) |
Immunosuppression | 15 (11.0) | 10 (7.9) |
Multimorbidity | 48 (35.3) | 50 (39.4) |
APACHE II score, mean (SD) | 22.7 (7.8) | 22.1 (7.5) |
SOFA score, mean (SD) | 7.8 (3.0) | 7.4 (3.4) |
Positive blood culture | 41 (30.1) | 45 (35.4) |
Clinical signs on admission | ||
Body temperature >38.0°C | 65 (47.8) | 63 (49.6) |
Body temperature <36.0°C | 10 (7.4) | 16 (12.6) |
Heart rate >90 beats/min | 103 (75.7) | 84 (66.1) |
Systolic blood pressure <100 mm Hg | 36 (26.5) | 40 (31.5) |
Respiratory rate ≥22 breaths/min | 103 (75.7) | 103 (81.1) |
Altered mental status | 53 (39.0) | 38 (29.9) |
qSOFA score ≥2, % | 61 (44.9) | 52 (40.9) |
Laboratory findings on admission | ||
CRP (mg/L), mean (SD) | 189 (142) | 186 (158) |
Creatinine (µmol/L), mean (SD) | 147 (95) | 183 (154) |
Lactate (mmol/L) mean (SD) | 3.5 (2.6) | 3.6 (2.8) |
Outcome parameters | ||
Septic shock | 114 (83.8) | 100 (78.7) |
Length of ICU stay in days, median (IQR) | 4.9 (2.2–11.9) | 5.8 (2.8–12.6) |
Length of hospital stay, median (IQR) | 13.4 (7.8–22.6) | 13.6 (9.6–22.5) |
Hospital mortality | 31 (22.8) | 32 (25.2) |
APACHE II, Acute Physiology and Chronic Health Evaluation II, CRP, C reactive protein; GP, general practitioner; ICU, intensive care unit; qSOFA, quick Sepsis-related Organ Failure Assessment.17